about
Compartmentalized glucose metabolism in Pseudomonas putida is controlled by the PtxS repressorSingle-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein.High specificity in CheR methyltransferase function: CheR2 of Pseudomonas putida is essential for chemotaxis, whereas CheR1 is involved in biofilm formation.Identification of ligands for bacterial sensor proteins.Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.Purification and characterization of Pseudomonas aeruginosa LasR expressed in acyl-homoserine lactone free Escherichia coli cultures.Assessment of the contribution of chemoreceptor-based signalling to biofilm formation.Identification of a chemoreceptor that specifically mediates chemotaxis toward metabolizable purine derivatives.Biosynthesis of the acetyl-CoA carboxylase-inhibiting antibiotic, andrimid in Serratia is regulated by Hfq and the LysR-type transcriptional regulator, AdmXIdentification of a Chemoreceptor for C2 and C3 Carboxylic AcidsTwo different mechanisms mediate chemotaxis to inorganic phosphate in Pseudomonas aeruginosa.Identification of new residues involved in intramolecular signal transmission in a prokaryotic transcriptional repressor.A mechanism for cancer-associated inactivation of NQO1 due to P187S and its reactivation by the consensus mutation H80R.Structural Basis for Polyamine Binding at the dCACHE Domain of the McpU Chemoreceptor from Pseudomonas putidaGlobal Protein Stabilization Does Not Suffice to Prevent Amyloid Fibril FormationThe cytotoxic domain of colicin E9 is a channel-forming endonucleaseAn auxin controls bacterial antibiotics productionCombining Structural Aggregation Propensity and Stability Predictions To Redesign Protein SolubilityEarly mechanisms of amyloid fibril nucleation in model and disease-related proteinsStructural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins
P50
Q28497356-F56E3702-699C-497B-960A-82A48871F007Q34793125-3A7B9FC6-AD44-4E9C-A054-7ABDE6F2BE88Q36386314-5FCA3C78-A97F-41B1-960E-7AAFAFE76C19Q38315454-0E4D9620-DFB7-4100-93BB-26FF4B6B4A02Q38618768-F232F55D-34E0-4E25-A797-907D84097898Q38828082-9DCD7BD1-62FB-4956-97FE-4BF7050DD7F2Q39274805-01776657-1EC7-4047-9CBC-0CA0C325D10DQ40216295-62CFAA51-3D5E-495F-B6F3-93E0A433D495Q40555850-AAB8AFE1-6D0D-4E69-9970-834D93C8307DQ40777716-E520022D-3EEE-4654-8BBF-0475F15087FFQ40863660-5A4F6DD2-2A58-49F8-9280-B8FC4A57D54CQ41834574-1AD68D6B-A348-4EDB-A8E1-297B1715DC4BQ41908178-F03442A4-A725-4356-BE9F-E4F8316DC213Q47848894-D60B82E4-2840-42A1-B0B0-A4F68BF24336Q58287833-F64585B1-7592-492F-AEB2-8BD509CEDBE7Q58434151-8510162F-B689-428E-B439-6DAA7E524778Q74139557-F834AE32-D8BA-4FFD-8E23-D736A9FFD03CQ90003531-C3703513-1514-46BE-868C-4077E1608059Q90415219-E4DBA167-BF7C-405F-B94E-AC277DA60C16Q92776107-CFC07554-2890-4DF0-8710-9649F3647E2CQ93129637-68DF1E1C-AE96-4181-A96A-CD2F73F80D2E
P50
description
researcher ORCID ID=0000-0002-2708-8589
@en
wetenschapper
@nl
name
Bertrand Morel
@en
Bertrand Morel
@nl
type
label
Bertrand Morel
@en
Bertrand Morel
@nl
prefLabel
Bertrand Morel
@en
Bertrand Morel
@nl
P106
P31
P496
0000-0002-2708-8589